Oncocyte Corporation
NASDAQ:OCX 4:00:00 PM EDT
| Market Cap (Intraday) | 26.37M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $3.26 |
| 50-Day MA | $3.64 |
| 200-Day MA | $5.58 |
Oncocyte Corporation Stock, NASDAQ:OCX
15 Cushing, Suite 102, Irvine, California 92618
United States of America
Phone: +1.949.409.7600
Number of Employees: 76
Description
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.